|
Market Closed -
Xetra
11:35:46 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 61.82 EUR | -0.80% |
|
+1.08% | -42.39% |
| 09-14 | Zoetis Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-14-2026 01:50 PM | |
| 08-25 | TD Cowen Adjusts Price Target on Zoetis to $94 From $104 | MT |
Company Valuation: Zoetis Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 115,457 | 68,303 | 90,615 | 73,508 | 55,448 | 28,798 | - | - |
| Change | - | -40.84% | 32.67% | -18.88% | -24.57% | -48.06% | - | - |
| Enterprise Value (EV) 1 | 118,564 | 72,626 | 95,138 | 78,091 | 62,178 | 35,918 | 35,177 | 34,506 |
| Change | - | -38.75% | 31% | -17.92% | -20.38% | -42.23% | -2.06% | -1.91% |
| P/E | 57.1x | 32.6x | 38.9x | 29.8x | 20.9x | 12.4x | 11.7x | 10.5x |
| PBR | 25.4x | 15.4x | 18.1x | 15.3x | 16.1x | 8.71x | 6.96x | 5.69x |
| PEG | - | 6.33x | 3x | 3.78x | 2.1x | -1.84x | 1.84x | 1x |
| Capitalization / Revenue | 14.8x | 8.45x | 10.6x | 7.94x | 5.86x | 3.12x | 3.04x | 2.92x |
| EV / Revenue | 15.2x | 8.99x | 11.1x | 8.44x | 6.57x | 3.89x | 3.71x | 3.49x |
| EV / EBITDA | 34.5x | 20.4x | 25.6x | 19.3x | 14.7x | 9.24x | 8.65x | 8.11x |
| EV / EBIT | 39.7x | 23.5x | 29.4x | 22.1x | 16.6x | 10.5x | 9.85x | 9.13x |
| EV / FCF | 68.3x | 54.8x | 58.7x | 34x | 27.2x | 15.1x | 12.5x | 11.8x |
| FCF Yield | 1.46% | 1.83% | 1.7% | 2.94% | 3.67% | 6.61% | 8.01% | 8.49% |
| Dividend per Share 2 | 1.075 | 1.35 | 1.557 | 1.796 | 2.03 | 2.116 | 2.272 | 2.488 |
| Rate of return | 0.44% | 0.92% | 0.79% | 1.1% | 1.61% | 3.04% | 3.26% | 3.57% |
| EPS 2 | 4.27 | 4.49 | 5.07 | 5.47 | 6.02 | 5.613 | 5.971 | 6.608 |
| Distribution rate | 25.2% | 30.1% | 30.7% | 32.8% | 33.7% | 37.7% | 38.1% | 37.7% |
| Net sales 1 | 7,776 | 8,080 | 8,544 | 9,256 | 9,467 | 9,237 | 9,477 | 9,877 |
| EBITDA 1 | 3,434 | 3,561 | 3,722 | 4,036 | 4,240 | 3,886 | 4,067 | 4,257 |
| EBIT 1 | 2,986 | 3,096 | 3,231 | 3,539 | 3,753 | 3,422 | 3,572 | 3,781 |
| Net income 1 | 2,037 | 2,114 | 2,344 | 2,486 | 2,673 | 2,362 | 2,388 | 2,532 |
| Net Debt 1 | 3,107 | 4,323 | 4,523 | 4,583 | 6,730 | 7,121 | 6,379 | 5,709 |
| Reference price 2 | 244.03 | 146.55 | 197.37 | 162.93 | 125.82 | 69.69 | 69.69 | 69.69 |
| Nbr of stocks (in thousands) | 473,126 | 466,072 | 459,114 | 451,165 | 440,693 | 413,224 | - | - |
| Announcement Date | 2/15/22 | 2/14/23 | 2/13/24 | 2/13/25 | 2/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 32.45x | 11.78x | 23.93x | 0.61% | 1,019B | |
| 28.48x | 6.32x | 17.7x | 2.09% | 617B | |
| 33.26x | 7.78x | 16.08x | 2.64% | 464B | |
| 104.98x | 5.87x | 24.89x | 2.36% | 356B | |
| 18.81x | 4.58x | 11.36x | 2.9% | 333B | |
| 19.83x | 5.17x | 12.78x | 3.09% | 267B | |
| 20.02x | 4.17x | 11.86x | 2.13% | 244B | |
| 25.46x | 6.66x | 11.86x | 2.5% | 218B | |
| -43.78x | 6.39x | 24.97x | 2.27% | 179B | |
| Average | 26.61x | 6.52x | 17.27x | 2.29% | 410.8B | |
| Weighted average by Cap. | 31.80x | 7.61x | 18.61x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ZTS Stock
- ZOE Stock
- Valuation Zoetis Inc.
Select your edition
All financial news and data tailored to specific country editions
